Hospice Medication Alert: Allergan Recalls Contaminated Eye Ointments
On August 8, 2015, Allergan has issued a voluntary nationwide recall on certain lots of various eye ointments due to contamination of black particle from unscrewing the cap from the aluminum tube. This black particle can potentially be introduced into the product and was found at time of use by a small number of customer. The reported adverse events include foreign body in the eye, superficial eye injury, pain, swelling and blurred vision.
Two of recalled ointments are sold over the counter. The ointments in question are:
- Refresh Lacri-Lube 3.5g and 7g for dry eye – OTC
- Refresh P.M. 3.5g for dry eye – OTC
- FML (fluorometholone ophthalmic ointment) 0.1%, 3.5g for eye inflammatory conditions – RX only
- Blephamide (sulfacetamide-prednisoone) 10%-2%, 3.5g – this is a combination of antibiotic and a corticosteroid usually used for infection, RX only.
This recall only applies to specific lots of the product listed above and does not affect any other Refresh or Allergan product. Specific information on product and lots can be found by clicking here. The lots subject to the recall have expiration dates that range from April 2017 to March 2018. This recall is extended to the patient level, so the pharmacies which have dispensed these products may have already contacted the patients who may have received these products. As an additional precaution, it is advised to check with your patients who are currently using these eye ointments and evaluate if they are affected by this recall.
Click here for more information on the recall.